Glück Conviction Score™ ⓘ
PVLA
PALVELLA THERAPEUTICS, INC.
Effektiv: Neutral
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
67,4
59 neu, 67 erhöht, 584,4M $ netto
Aktivist
31,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 119.86 | -9.2 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 96.50 | +12.8 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 111.60 | EMA50: 115.29 | |
| MACD-Histogramm | Bärisch | 10 % | -0.392 | Bearisch | |
| RSI(14) | Neutral | 10 % | 45.5 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 44.1 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 16.6 | +DI: 19.5 / −DI: 23.8 | |
| Z-Score(60) | Neutral | 5 % | -1.32 | In Range | |
| 52W-Position | Neutral | 5 % | 69.1 % | Hoch 148.34 / Tief 20.51 | |
| Bollinger(20,2σ) | Neutral | 5 % | 37.9 % | Upper 121.41 / Mid 111.26 / Lower 101.12 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.2201 | R²=0.23 / annualisiert -46.5 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -891 | 111,30 | -99.165,00 | -53,0% | |
| 2026-05-20 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -48 | 111,90 | -5.370,96 | -2,9% | |
| 2026-05-20 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -3.363 | 110,35 | -371.094,94 | -198,4% | |
| 2026-04-15 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -639 | 129,17 | -82.539,12 | -44,1% | |
| 2026-04-15 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -561 | 128,23 | -71.939,78 | -38,5% | |
| 2026-04-15 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -100 | 130,33 | -13.033,00 | -7,0% | |
| 2026-04-15 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -1.502 | 125,96 | -189.198,98 | -101,1% | |
| 2026-04-15 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -1.500 | 127,13 | -190.688,10 | -101,9% | |
| 2026-03-30 | JENKINS GEORGE M | Director | Open Market Purchase | 445 | 112,30 | 49.973,50 | +26,7% | |
| 2026-03-18 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -1.730 | 118,37 | -204.776,81 | -109,5% | |
| 2026-03-18 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -304 | 119,08 | -36.200,84 | -19,4% | |
| 2026-03-18 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -2.268 | 117,56 | -266.633,34 | -142,5% | |
| 2026-02-27 | JENKINS GEORGE M | Director | Open Market Purchase | 4.000 | 125,00 | 500.000,00 | +267,3% | |
| 2026-02-27 | HERON ELAINE J | Director | Open Market Purchase | 2.400 | 125,00 | 300.000,00 | +160,4% | |
| 2026-02-18 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -3.026 | 79,16 | -239.528,78 | -128,1% | |
| 2026-02-18 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -1.276 | 79,97 | -102.035,47 | -54,5% | |
| 2026-01-21 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -553 | 95,49 | -52.805,97 | -28,2% | |
| 2026-01-21 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -3.749 | 97,94 | -367.177,06 | -196,3% | |
| 2025-12-17 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -4.302 | 96,47 | -415.022,54 | -221,9% | |
| 2025-11-19 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -2.802 | 86,51 | -242.387,85 | -129,6% | |
| 2025-11-19 | Goin Kathleen | Officer, Chief Operating Officer | Open Market Sale | -1.500 | 85,72 | -128.577,45 | -68,7% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.153.496 | 892.400 | 261.096 | 143.783.276 | Aufgestockt | +29,3% | |
| First Light Asset Management, LLC | 980.758 | 709.141 | 271.617 | 122.251.485 | Aufgestockt | +38,3% | |
| BVF INC/IL | 960.989 | 879.009 | 81.980 | 119.787.279 | Aufgestockt | +9,3% | |
| Frazier Life Sciences Management, L.P. | 882.400 | 722.400 | 160.000 | 109.991.160 | Aufgestockt | +22,1% | |
| BlackRock, Inc. | 686.853 | 559.065 | 127.788 | 85.616.227 | Aufgestockt | +22,9% | |
| JENNISON ASSOCIATES LLC | 640.611 | 387.483 | 253.128 | 79.852.163 | Aufgestockt | +65,3% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 477.294 | 0 | 477.294 | 59.494.697 | Neu | +100,0% | |
| VANGUARD GROUP INC | 560.616 | 0 | 560.616 | 58.679.676 | Neu | +100,0% | |
| STATE STREET CORP | 458.999 | 420.462 | 38.537 | 57.214.225 | Aufgestockt | +9,2% | |
| FEDERATED HERMES, INC. | 433.015 | 368.038 | 64.977 | 53.975.320 | Aufgestockt | +17,7% | |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 374.035 | 0 | 374.035 | 46.623.461 | Neu | +100,0% | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 389.420 | 0 | 389.420 | 40.760.591 | Neu | +100,0% | |
| Woodline Partners LP | 317.517 | 300.536 | 16.981 | 39.578.494 | Aufgestockt | +5,7% | |
| Siren, L.L.C. | 257.485 | 75.000 | 182.485 | 32.095.505 | Aufgestockt | +243,3% | |
| Caption Management, LLC | 237.100 | 191.300 | 45.800 | 29.554.515 | Aufgestockt | +23,9% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 233.248 | 101.748 | 131.500 | 29.049.685 | Aufgestockt | +129,2% | |
| PERCEPTIVE ADVISORS LLC | 266.287 | 0 | 266.287 | 27.872.260 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 262.835 | 269.027 | -6.192 | 27.510.939 | Reduziert | -2,3% | |
| FMR LLC | 215.808 | 231.760 | -15.952 | 26.900.498 | Reduziert | -6,9% | |
| MPM BioImpact LLC | 206.404 | 205.745 | 659 | 25.728.259 | Aufgestockt | +0,3% | |
| GEODE CAPITAL MANAGEMENT, LLC | 205.609 | 178.992 | 26.617 | 25.636.522 | Aufgestockt | +14,9% | |
| PRIMECAP MANAGEMENT CO/CA/ | 195.030 | 0 | 195.030 | 24.310.490 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 194.179 | 98.935 | 95.244 | 24.204.412 | Aufgestockt | +96,3% | |
| Artisan Partners Limited Partnership | 193.796 | 211.553 | -17.757 | 24.156.671 | Reduziert | -8,4% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 192.908 | 38.200 | 154.708 | 24.045.982 | Aufgestockt | +405,0% | |
| ORBIMED ADVISORS LLC | 184.600 | 0 | 184.600 | 23.010.390 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 179.922 | 0 | 179.922 | 22.427.277 | Neu | +100,0% | |
| EMERALD ADVISERS, LLC | 161.500 | 0 | 161.500 | 20.130.975 | Neu | +100,0% | |
| First Turn Management, LLC | 148.093 | 0 | 148.093 | 18.459.792 | Neu | +100,0% | |
| MORGAN STANLEY | 127.987 | 220.662 | -92.675 | 15.953.581 | Reduziert | -42,0% | |
| EMERALD MUTUAL FUND ADVISERS TRUST | 105.820 | 0 | 105.820 | 13.190.463 | Neu | +100,0% | |
| UBS Group AG | 104.537 | 36.505 | 68.032 | 13.030.537 | Aufgestockt | +186,4% | |
| BALYASNY ASSET MANAGEMENT L.P. | 96.726 | 108.880 | -12.154 | 12.056.896 | Reduziert | -11,2% | |
| MILLENNIUM MANAGEMENT LLC | 93.646 | 3.480 | 90.166 | 11.672.974 | Aufgestockt | +2591,0% | |
| Clio Asset Management LLC | 90.757 | 91.642 | -885 | 11.312.860 | Reduziert | -1,0% | |
| APIS CAPITAL ADVISORS, LLC | 89.000 | 0 | 89.000 | 11.093.850 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 88.160 | 77.297 | 10.863 | 10.989.144 | Aufgestockt | +14,1% | |
| NEXTBio Capital Management LP | 82.686 | 82.686 | 0 | 10.306.810 | Unverändert | 0,0% | |
| Aberdeen Group plc | 81.081 | 0 | 81.081 | 10.106.747 | Neu | +100,0% | |
| Avidity Partners Management LP | 70.000 | 19.300 | 50.700 | 8.725.500 | Aufgestockt | +262,7% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 69.901 | 47.681 | 22.220 | 8.713.159 | Aufgestockt | +46,6% | |
| AWM Investment Company, Inc. | 69.416 | 69.416 | 0 | 8.652.704 | Unverändert | 0,0% | |
| Ikarian Capital, LLC | 64.626 | 0 | 64.626 | 8.055.631 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 64.371 | 54.490 | 9.881 | 8.023.846 | Aufgestockt | +18,1% | |
| SEVEN GRAND MANAGERS, LLC | 60.000 | 0 | 60.000 | 7.479.000 | Neu | +100,0% | |
| Clearbridge Investments, LLC | 59.410 | 60.628 | -1.218 | 7.405.488 | Reduziert | -2,0% | |
| CITADEL ADVISORS LLC | 56.472 | 2.636 | 53.836 | 7.039.235 | Aufgestockt | +2042,3% | |
| Neuberger Berman Group LLC | 49.103 | 44.901 | 4.202 | 6.120.689 | Aufgestockt | +9,4% | |
| Invesco Ltd. | 48.527 | 54.273 | -5.746 | 6.048.892 | Reduziert | -10,6% | |
| Lisanti Capital Growth, LLC | 41.445 | 41.470 | -25 | 5.166.119 | Reduziert | -0,1% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.153.496 | 892.400 | +29,3% | 143.783.276 | 8,83 |
| First Light Asset Management, LLC | 980.758 | 709.141 | +38,3% | 122.251.485 | 7,51 |
| BVF INC/IL | 960.989 | 879.009 | +9,3% | 119.787.279 | 7,36 |
| Frazier Life Sciences Management, L.P. | 882.400 | 722.400 | +22,1% | 109.991.160 | 6,76 |
| BlackRock, Inc. | 686.853 | 559.065 | +22,9% | 85.616.227 | 5,26 |
| JENNISON ASSOCIATES LLC | 640.611 | 387.483 | +65,3% | 79.852.163 | 4,91 |
| VANGUARD CAPITAL MANAGEMENT LLC | 477.294 | 0 | +100,0% | 59.494.697 | 3,66 |
| STATE STREET CORP | 458.999 | 420.462 | +9,2% | 57.214.225 | 3,52 |
| FEDERATED HERMES, INC. | 433.015 | 368.038 | +17,7% | 53.975.320 | 3,32 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 374.035 | 0 | +100,0% | 46.623.461 | 2,86 |
| Woodline Partners LP | 317.517 | 300.536 | +5,7% | 39.578.494 | 2,43 |
| Siren, L.L.C. | 257.485 | 75.000 | +243,3% | 32.095.505 | 1,97 |
| Caption Management, LLC | 237.100 | 191.300 | +23,9% | 29.554.515 | 1,82 |
| EVENTIDE ASSET MANAGEMENT, LLC | 233.248 | 101.748 | +129,2% | 29.049.685 | 1,78 |
| ALLIANCEBERNSTEIN L.P. | 262.835 | 269.027 | -2,3% | 27.510.939 | 1,69 |
| FMR LLC | 215.808 | 231.760 | -6,9% | 26.900.498 | 1,65 |
| MPM BioImpact LLC | 206.404 | 205.745 | +0,3% | 25.728.259 | 1,58 |
| GEODE CAPITAL MANAGEMENT, LLC | 205.609 | 178.992 | +14,9% | 25.636.522 | 1,58 |
| PRIMECAP MANAGEMENT CO/CA/ | 195.030 | 0 | +100,0% | 24.310.490 | 1,49 |
| GOLDMAN SACHS GROUP INC | 194.179 | 98.935 | +96,3% | 24.204.412 | 1,49 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 183 | 14,6 | 1.761 |
| 31.12.2025 | ✓ | 143 | 10,3 | 1.081 |
| 30.09.2025 | ✓ | 98 | 8,7 | 542 |
| 30.06.2025 | ✓ | 63 | 5,9 | 131 |
| 31.03.2025 | ✓ | 40 | 5,0 | 140 |
| 31.12.2024 | ✓ | 33 | 4,0 | 49 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| ALLIANCEBERNSTEIN L.P. | 269.027 | 28.159.056 |
| Artisan Partners Limited Partnership | 211.553 | 22.143.253 |
| Caption Management, LLC | 191.300 | 20.023.371 |
| EVENTIDE ASSET MANAGEMENT, LLC | 101.748 | 10.649.963 |
| NEXTBio Capital Management LP | 82.686 | 8.654.744 |
| Siren, L.L.C. | 75.000 | 7.850.250 |
| Clearbridge Investments, LLC | 60.628 | 6.345.881 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 47.681 | 4.990.771 |
| Neuberger Berman Group LLC | 44.901 | 4.699.787 |
| Lisanti Capital Growth, LLC | 41.470 | 4.340.665 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 389.420 | 354.525 | +1016.0 % | 40.760.591 |
| STATE STREET CORP | 420.462 | 283.211 | +206.3 % | 44.009.758 |
| JENNISON ASSOCIATES LLC | 387.483 | 280.573 | +262.4 % | 40.557.846 |
| First Light Asset Management, LLC | 709.141 | 167.597 | +30.9 % | 74.225.788 |
| MPM BioImpact LLC | 205.745 | 138.322 | +205.2 % | 21.535.329 |
| FMR LLC | 231.760 | 121.314 | +109.8 % | 24.258.346 |
| MORGAN STANLEY | 220.662 | 82.157 | +59.3 % | 23.096.692 |
| BlackRock, Inc. | 559.065 | 71.449 | +14.7 % | 58.517.334 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 892.400 | 70.000 | +8.5 % | 93.407.508 |
| VANGUARD GROUP INC | 560.616 | 65.960 | +13.3 % | 58.679.676 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BVF INC/IL | 879.009 | -282.240 | -24.3 % | 92.005.872 |
| Point72 Asset Management, L.P. | 77.297 | -240.012 | -75.6 % | 8.090.677 |
| GOLDMAN SACHS GROUP INC | 98.935 | -137.695 | -58.2 % | 10.355.526 |
| PERCEPTIVE ADVISORS LLC | 266.287 | -128.806 | -32.6 % | 27.872.260 |
| Samsara BioCapital, LLC | 104.817 | -104.817 | -50.0 % | 10.971.195 |
| RENAISSANCE TECHNOLOGIES LLC | 22.530 | -67.167 | -74.9 % | 2.358.215 |
| BALYASNY ASSET MANAGEMENT L.P. | 108.880 | -57.655 | -34.6 % | 11.396.470 |
| Blue Owl Capital Holdings LP | 40.259 | -55.000 | -57.7 % | 4.213.910 |
| Woodline Partners LP | 300.536 | -45.213 | -13.1 % | 31.457.103 |
| FRED ALGER MANAGEMENT, LLC | 150.026 | -36.725 | -19.7 % | 15.703.221 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 17.02.2026 | First Light Asset Management, LLC | Passiv (13G) | 7,49 % | 887.031 | Neu | |
| 17.02.2026 | Mathew P. Arens | Passiv (13G) | 7,49 % | 887.031 | Neu | |
| 17.02.2026 | BVF INC/IL | Passiv (13G/A) | 7,10 % | 879.009 | -2,89 pp | |
| 17.02.2026 | BVF Partners OS Ltd. | Passiv (13G/A) | 0,40 % | 53.187 | -0,10 pp | |
| 17.02.2026 | BVF GP HOLDINGS LLC | Passiv (13G/A) | 6,60 % | 813.085 | -2,80 pp | |
| 17.02.2026 | BIOTECHNOLOGY VALUE FUND II LP | Passiv (13G/A) | 2,80 % | 341.883 | -1,20 pp | |
| 17.02.2026 | BIOTECHNOLOGY VALUE FUND L P | Passiv (13G/A) | 3,80 % | 471.202 | -1,60 pp | |
| 17.02.2026 | Biotechnology Value Trading Fund OS LP | Passiv (13G/A) | 0,40 % | 53.187 | -0,10 pp | |
| 17.02.2026 | BVF I GP LLC | Passiv (13G/A) | 3,80 % | 471.202 | -1,60 pp | |
| 17.02.2026 | BVF II GP LLC | Passiv (13G/A) | 2,80 % | 341.883 | -1,20 pp | |
| 17.02.2026 | LAMPERT MARK N | Passiv (13G/A) | 7,10 % | 879.009 | -2,89 pp | |
| 17.02.2026 | BVF PARTNERS L P/IL | Passiv (13G/A) | 7,10 % | 879.009 | -2,89 pp | |
| 13.02.2026 | Patrick J. Heron | Passiv (13G/A) | 0,00 % | 4.730 | 0,00 pp | |
| 13.02.2026 | FHMLS X, L.L.C. | Passiv (13G/A) | 0,00 % | 4.730 | 0,00 pp | |
| 13.02.2026 | FHMLS XII, L.P. | Passiv (13G/A) | 0,00 % | 3.793 | 0,00 pp | |
| 13.02.2026 | James N. Topper | Passiv (13G/A) | 0,00 % | 4.730 | 0,00 pp | |
| 13.02.2026 | FHMLS XI, L.P. | Passiv (13G/A) | 0,10 % | 7.517 | 0,00 pp | |
| 13.02.2026 | FHMLSP, L.L.C. | Passiv (13G/A) | 6,00 % | 706.360 | +1,10 pp | |
| 13.02.2026 | Frazier Life Sciences Public Fund, L.P. | Passiv (13G/A) | 6,00 % | 706.360 | +1,10 pp | |
| 13.02.2026 | Frazier Life Sciences X, L.P. | Passiv (13G/A) | 0,00 % | 4.730 | 0,00 pp | |
| 13.02.2026 | FHMLS XI, L.L.C. | Passiv (13G/A) | 0,10 % | 7.517 | 0,00 pp | |
| 13.02.2026 | FHMLS XII, L.L.C. | Passiv (13G/A) | 0,00 % | 3.793 | 0,00 pp | |
| 13.02.2026 | Frazier Life Sciences XII, L.P. | Passiv (13G/A) | 0,00 % | 3.793 | 0,00 pp | |
| 13.02.2026 | FHMLS X, L.P. | Passiv (13G/A) | 0,00 % | 4.730 | 0,00 pp | |
| 13.02.2026 | FHMLSP, L.P. | Passiv (13G/A) | 6,00 % | 706.360 | +1,10 pp | |
| 13.02.2026 | Frazier Life Sciences XI, L.P. | Passiv (13G/A) | 0,10 % | 7.517 | 0,00 pp | |
| 14.11.2025 | BVF PARTNERS L P/IL | Passiv (13G/A) | 9,99 % | 1.181.194 | Neu | |
| 14.11.2025 | Biotechnology Value Trading Fund OS LP | Passiv (13G/A) | 0,50 % | 54.840 | -0,50 pp | |
| 14.11.2025 | BVF INC/IL | Passiv (13G/A) | 9,99 % | 1.181.194 | Neu | |
| 14.11.2025 | BVF II GP LLC | Passiv (13G/A) | 4,00 % | 474.740 | +1,50 pp | |
| 14.11.2025 | BIOTECHNOLOGY VALUE FUND L P | Passiv (13G/A) | 5,40 % | 634.307 | Neu | |
| 14.11.2025 | BVF I GP LLC | Passiv (13G/A) | 5,40 % | 634.307 | -1,80 pp | |
| 14.11.2025 | LAMPERT MARK N | Passiv (13G/A) | 9,99 % | 1.181.194 | Neu | |
| 14.11.2025 | BIOTECHNOLOGY VALUE FUND II LP | Passiv (13G/A) | 4,00 % | 474.740 | Neu | |
| 14.11.2025 | BVF GP HOLDINGS LLC | Passiv (13G/A) | 9,40 % | 1.109.047 | Neu | |
| 14.11.2025 | BVF Partners OS Ltd. | Passiv (13G/A) | 0,50 % | 54.840 | -0,50 pp | |
| 13.11.2025 | AVERILL MASTER FUND, LTD. | Passiv (13G/A) | 6,50 % | 714.463 | Neu | |
| 13.11.2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | Passiv (13G/A) | 7,40 % | 822.400 | -1,20 pp | |
| 13.11.2025 | AARON COWEN | Passiv (13G/A) | 7,40 % | 822.400 | Neu | |
| 14.08.2025 | Samsara BioCapital GP, LLC | Passiv (13G/A) | 3,10 % | 339.743 | -3,00 pp |
Stammdaten
Palvella Therapeutics, Inc., ein klinisches Biopharmaunternehmen, konzentriert sich auf die Entwicklung und Vermarktung neuartiger Therapien zur Behandlung von Patienten mit ernsthaften und seltenen genetischen Hauterkrankungen. Sein führender Produktkandidat ist QTORIN 3,9 % Rapamycin-Anhydrid-Gel (QTORIN Rapamycin), das sich in Phase-3-Kliniktests zur Behandlung mikrozystischer lymphatischer Malformationen sowie in Phase-2-Kliniktests zur Behandlung kutaner venöser Malformationen befindet. Das Unternehmen entwickelt zudem QTORIN Rapamycin zur Behandlung weiterer mTOR-abhängiger Hauterkrankungen. Das Unternehmen hat seinen Sitz in Wayne, Pennsylvania.
Unternehmen & Branche
| Name | PALVELLA THERAPEUTICS, INC. |
|---|---|
| Ticker | PVLA |
| CIK | 0001583648 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 697947109 |
|---|---|
| ISIN | US6979471090 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,32 Mrd. USD |
Bewertung
| KBV (P/B) | 47,01 |
|---|---|
| FCF-Rendite | -1,9 % |
Qualität & Bilanz
| ROIC | -145,8 % vs. -69,7 % (2021) ▼ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | – | – | – | 2,11 | 46,31 | |
| FCF-Rendite | – | – | – | -8,2 % | -1,9 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | -165,0 % | -167,8 % | -27,7 % | – | – | |
| Nettomarge | -145,6 % | -128,5 % | 43,7 % | – | – | |
| ROIC | -69,7 % | – | – | -27,8 % | -145,8 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -15.767.000 | -1,20 | 263.759.000 | 232.313.000 | |
| 2025-12-31 | 10-K | -41.715.000 | -3,71 | 59.559.000 | 27.983.000 | |
| 2025-09-30 | 10-Q | -11.345.000 | -1,03 | 66.937.000 | 38.682.000 | |
| 2025-06-30 | 10-Q | -9.471.000 | -0,86 | 73.747.000 | 47.780.000 | |
| 2025-03-31 | 10-Q | -8.185.000 | -0,74 | 79.439.000 | 55.577.000 | |
| 2024-12-31 | 10-K | -17.434.000 | -7,83 | 88.234.000 | 62.607.000 | |
| 2024-09-30 | 10-Q | 0 | -2.887.000 | -2,19 | 20.522.000 | 16.268.000 |
| 2024-06-30 | 10-Q | 0 | -3.590.000 | -2,76 | 25.051.000 | 18.705.000 |
| 2024-03-31 | 10-Q | 53.000 | -4.892.000 | -1,54 | 29.497.000 | 21.964.000 |
| 2023-12-31 | 10-K | 42.810.000 | 18.691.000 | 2,17 | 7.548.000 | -74.483.000 |
| 2023-09-30 | 10-Q | 19.520.000 | -10.752.000 | -8,70 | 59.376.000 | 30.510.000 |
| 2023-06-30 | 10-Q | 20.055.000 | 3.976.000 | 3,62 | 87.544.000 | 40.498.000 |
| 2023-03-31 | 10-Q | 1.936.000 | -13.183.000 | 82.258.000 | 15.458.000 | |
| 2022-12-31 | 10-K | 25.902.000 | -33.277.000 | 95.490.000 | -93.777.000 | |
| 2022-09-30 | 10-Q | 5.370.000 | -9.736.000 | 99.163.000 | 35.767.000 | |
| 2022-06-30 | 10-Q | 3.698.000 | -10.338.000 | -0,14 | 114.309.000 | 44.365.000 |
| 2022-03-31 | 10-Q | 10.988.000 | -5.101.000 | -0,07 | 137.115.000 | 53.450.000 |
| 2021-12-31 | 10-K | 31.418.000 | -45.738.000 | -0,71 | 153.560.000 | 50.755.000 |
| 2021-09-30 | 10-Q | 4.057.000 | -16.536.000 | -0,24 | 164.184.000 | 53.853.000 |
| 2021-06-30 | 10-Q | 3.285.000 | -15.498.000 | -0,25 | 155.030.000 | 46.721.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | – | -1,20 |
| Q3 2025 | 30.09.2025 | 12.11.2025 | – | -1,03 |
| Q2 2025 | 30.06.2025 | 12.11.2025 | – | -0,86 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | – | -0,74 |
| Q3 2024 | 30.09.2024 | 12.11.2025 | 0 USD | -3,94 |
| Q2 2024 | 30.06.2024 | 12.11.2025 | 0 USD | -2,47 |
| Q1 2024 | 31.03.2024 | 12.11.2025 | 53.000 USD | -1,54 |
| Q3 2023 | 30.09.2023 | 13.11.2024 | 19,5 Mio. USD | -8,70 |
| Q2 2023 | 30.06.2023 | 14.08.2024 | 20,1 Mio. USD | 3,62 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 31.03.2026 | 10-K | 31.12.2025 | 90 Tage | SEC » |
| 12.11.2025 | 10-Q | 30.09.2025 | 43 Tage | SEC » |
| 14.08.2025 | 10-Q | 30.06.2025 | 45 Tage | SEC » |
| 15.05.2025 | 10-Q | 31.03.2025 | 45 Tage | SEC » |
| 31.03.2025 | 10-K | 31.12.2024 | 90 Tage | SEC » |
| 13.11.2024 | 10-Q | 30.09.2024 | 44 Tage | SEC » |
| 14.08.2024 | 10-Q | 30.06.2024 | 45 Tage | SEC » |
| 15.05.2024 | 10-Q | 31.03.2024 | 45 Tage | SEC » |
| 29.04.2024 | 10-K/A | 31.12.2023 | 120 Tage | SEC » |
| 29.03.2024 | 10-K | 31.12.2023 | 89 Tage | SEC » |
| 14.11.2023 | 10-Q | 30.09.2023 | 45 Tage | SEC » |
| 10.08.2023 | 10-Q | 30.06.2023 | 41 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 31.03.2023 | 10-K | 31.12.2022 | 90 Tage | SEC » |
| 04.11.2022 | 10-Q | 30.09.2022 | 35 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 06.07.2022 | 10-K/A | 31.12.2021 | 187 Tage | SEC » |
| 11.05.2022 | 10-Q | 31.03.2022 | 41 Tage | SEC » |
| 02.03.2022 | 10-K | 31.12.2021 | 61 Tage | SEC » |
| 02.11.2021 | 10-Q | 30.09.2021 | 33 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 17.05.2021 | 10-Q | 31.03.2021 | 47 Tage | SEC » |
| 31.03.2021 | 10-K | 31.12.2020 | 90 Tage | SEC » |
| 04.11.2020 | 10-Q | 30.09.2020 | 35 Tage | SEC » |
| 10.08.2020 | 10-Q | 30.06.2020 | 41 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (13.04.2026)
HOCH Abgang Schlüsselpersonen (13.04.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 13.04.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 12.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | herein. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 13.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 26.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 04.08.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 27.06.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 29.06.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 08.01.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 1.431 | 120,57 | 172.536 |
| 2026-05-13 | 89 | 125,79 | 11.195 |
| 2026-05-12 | 2.617 | 122,09 | 319.510 |
| 2026-05-11 | 17 | 121,29 | 2.062 |
| 2026-05-08 | 2.639 | 113,26 | 298.893 |
| 2026-05-06 | 1.488 | 129,47 | 192.651 |
| 2026-04-20 | 116 | 130,01 | 15.081 |
| 2026-04-16 | 238 | 128,63 | 30.614 |
| 2026-04-15 | 254 | 129,53 | 32.901 |
| 2026-04-10 | 2.704 | 130,20 | 352.061 |
| 2026-04-09 | 23 | 123,17 | 2.833 |
| 2026-04-08 | 5.810 | 120,03 | 697.374 |
| 2026-04-07 | 3.547 | 119,86 | 425.143 |
| 2026-03-30 | 7 | 112,37 | 787 |
| 2026-03-27 | 475 | 117,61 | 55.865 |
| 2026-03-26 | 1.000 | 120,39 | 120.390 |
| 2026-03-25 | 109 | 116,23 | 12.669 |
| 2026-03-24 | 273 | 117,04 | 31.952 |
| 2026-03-20 | 85 | 113,91 | 9.682 |
| 2026-03-18 | 1.816 | 120,80 | 219.373 |
| 2026-03-17 | 4.446 | 126,05 | 560.418 |
| 2026-03-16 | 1.812 | 122,06 | 221.173 |
| 2026-03-13 | 63 | 136,60 | 8.606 |
| 2026-03-10 | 3.243 | 136,70 | 443.318 |
| 2026-03-06 | 1.378 | 134,95 | 185.961 |
| 2026-03-05 | 14.286 | 135,49 | 1.935.610 |
| 2026-03-02 | 11.278 | 135,02 | 1.522.756 |
| 2026-02-25 | 24 | 120,41 | 2.890 |
| 2026-02-18 | 285 | 80,09 | 22.826 |
| 2026-02-09 | 570 | 82,20 | 46.854 |
| 2026-02-06 | 1.150 | 76,43 | 87.895 |
| 2026-02-05 | 400 | 82,01 | 32.804 |
| 2026-01-16 | 505 | 103,98 | 52.510 |
| 2026-01-13 | 113 | 100,49 | 11.355 |
| 2026-01-09 | 546 | 97,38 | 53.169 |
| 2026-01-07 | 2.092 | 90,43 | 189.180 |
| 2026-01-05 | 14.780 | 100,28 | 1.482.138 |
| 2026-01-02 | 997 | 104,67 | 104.356 |
| 2025-12-30 | 100 | 101,15 | 10.115 |
| 2025-12-29 | 100 | 103,37 | 10.337 |
| 2025-12-26 | 406 | 105,83 | 42.967 |
| 2025-12-24 | 4.190 | 100,27 | 420.131 |
| 2025-12-23 | 1.590 | 109,07 | 173.421 |
| 2025-12-22 | 6.360 | 99,73 | 634.283 |
| 2025-12-18 | 3.662 | 92,01 | 336.941 |
| 2025-12-16 | 56.113 | 88,98 | 4.992.935 |
| 2025-12-15 | 810 | 98,58 | 79.850 |